Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NVTA - Invitae Corp


Previous close
0.019
0   0%

Share volume: 22,459,258
Last Updated: Wed 14 Feb 2024 06:00:00 AM CET
Medical Laboratories : -2.05%

PREVIOUS CLOSE
CHG
CHG%

$0.02
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
49%
Profitability 50%
Dept financing 20%
Liquidity 75%
Performance 50%
Company vs Stock growth
vs
Performance
5 Days
-24.00%
1 Month
-24.00%
3 Months
-24.00%
6 Months
-24.00%
1 Year
-24.00%
2 Year
-24.00%
Key data
Stock price
$0.02
P/E Ratio 
-0.00
DAY RANGE
$0.01 - $0.02
EPS 
-$5.58
52 WEEK RANGE
$0.02 - $0.07
52 WEEK CHANGE
-$0.24
MARKET CAP 
5.443 M
YIELD 
N/A
SHARES OUTSTANDING 
286.493 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$50,444,626
AVERAGE 30 VOLUME 
$50,444,626
Company detail
CEO:
Region: US
Website: https://www.invitae.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Medical Laboratories
Sector: Health Care and Social Assistance

invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.

Recent news